Our mission is to unlock drug discovery for challenging & "undruggable" pharmaceutical targets with Self-Purified DNA-Encoded Libraries
Pure-DEL has raised €161k across 1 funding round from 1 investor, most recently a round in Nov 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-21 | Other | €161k |
| Venture Kick |
| View deal → |
